Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group
Giacomo d’Andrea, Stefania Chiappini, Roger S. McIntyre, et al.
American Journal of Geriatric Psychiatry (2023) Vol. 31, Iss. 12, pp. 1032-1041
Open Access | Times Cited: 22

Showing 22 citing articles:

The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data
Giacomo d’Andrea, Mauro Pettorruso, Giorgio Di Lorenzo, et al.
Journal of Affective Disorders (2023) Vol. 348, pp. 314-322
Closed Access | Times Cited: 24
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING)
Mauro Pettorruso, Roberto Guidotti, Giacomo d’Andrea, et al.
Psychiatry Research (2023) Vol. 327, pp. 115378-115378
Open Access | Times Cited: 23
Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta, Canada
Carson Chrenek, Bryan Duong, Atul Khullar, et al.
Frontiers in Psychiatry (2024) Vol. 14
Open Access | Times Cited: 6
Facts and myths about use of esketamine for treatment-resistant depression: a narrative clinical review
Matteo Di Vincenzo, Vassilis Martiadis, Bianca Della Rocca, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 5
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study
Natalie Mills, Stevan Nikolin, Nick Glozier, et al.
The British Journal of Psychiatry (2025), pp. 1-7
Closed Access
Ketamine treatment for depression in elderly inpatients: an observational case series
Benedikt Römer, Stian S. Maroni, Espen Fevang, et al.
Journal of Affective Disorders Reports (2025), pp. 100904-100904
Open Access
The Patient’s Perspective on the Effects of Intranasal Esketamine in Treatment-Resistant Depression
Maria Pepe, Giovanni Bartolucci, Ilaria Marcelli, et al.
Brain Sciences (2023) Vol. 13, Iss. 10, pp. 1494-1494
Open Access | Times Cited: 10
Dopaminergic dysfunction in the left putamen of patients with major depressive disorder
Antonio Maria D’Onofrio, Daniele Antonio Pizzuto, Rana Batir, et al.
Journal of Affective Disorders (2024) Vol. 357, pp. 107-115
Closed Access | Times Cited: 3
Intravenous (IV) ketamine versus intranasal esketamine for depression– Advantage IV ketamine?
Balwinder Singh, Simon Kung, Jennifer L. Vande Voort
Journal of Affective Disorders (2024) Vol. 356, pp. 564-567
Closed Access | Times Cited: 3
Exploring the correlation between cardiovascular adverse events and antidepressant use: A retrospective pharmacovigilance analysis based on the FDA Adverse Event Reporting System database
Zhanzhang Wang, Haoyang Lu, Yuandan Li, et al.
Journal of Affective Disorders (2024) Vol. 367, pp. 96-108
Closed Access | Times Cited: 3
Comparing the adverse effects of ketamine and esketamine between genders using FAERS data
Xinxia Yang, Dongdong Chen
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Use of Esketamine Nasal Spray in Patients with Treatment‐Resistant Depression in Routine Practice: A Real‐World French Study
Ludovic Samalin, Lila Mékaoui, Maud Rothärmel, et al.
Depression and Anxiety (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 2
Heart Rate Variability as a Potential Predictor of Response to Intranasal Esketamine in Patients with Treatment-Resistant Depression: A Preliminary Report
Lorenzo Moccia, Giovanni Bartolucci, Maria Pepe, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4767-4767
Open Access | Times Cited: 2
Efficacy of esketamine for perinatal depression: a systematic review and meta-analysis
Sabrina Wong, Gia Han Le, Angela T.H. Kwan, et al.
CNS Spectrums (2024) Vol. 29, Iss. 5, pp. 326-334
Open Access | Times Cited: 2
Exploring the potential of Esketamine in the treatment of bipolar depression
Bernardo Dell’Osso, Giovanni Martinotti
European Neuropsychopharmacology (2023) Vol. 77, pp. 21-23
Closed Access | Times Cited: 5
Unveiling potential adverse events associated with escitalopram oxalate: A real-world analysis based FDA adverse event reporting system database
Ying Jiang, Yusi Cheng, Z Du, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 6, pp. 567-578
Closed Access | Times Cited: 1
Overcoming treatment-resistant depression with machine-learning based tools: a study protocol combining EEG and clinical data to personalize glutamatergic and brain stimulation interventions (SelecTool Project)
Mauro Pettorruso, Giorgio Di Lorenzo, Beatrice Benatti, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study
Giacomo d’Andrea, Andrea Miuli, Mauro Pettorruso, et al.
Journal of Affective Disorders (2024) Vol. 367, pp. 583-588
Closed Access | Times Cited: 1
Adequate management of the disease in elderly patients
Ulrich Hemmeter, Cristina Rothenbücher, Christian A. Koch, et al.
(2024), Iss. 12
Open Access
Effects of Volatile Anaesthetics on Incidence of Postoperative Depression and Anxiety Symptoms in Elderly Patients: a Retrospective Analysis of a Prospective Cohort Study
Shaohua You, Xinyu Hao, Fuyang Cao, et al.
Journal of Psychiatric Research (2024) Vol. 181, pp. 179-187
Closed Access
Finally, New Hope for the Treatment of LLTRD
Marie Anne Gebara, Patrick J. Brown, Steven P. Roose
American Journal of Geriatric Psychiatry (2023) Vol. 31, Iss. 12, pp. 1042-1044
Closed Access | Times Cited: 1
Intranasal esketamine as tool for rapid cycling bipolar disorder: A case report of successful mood stabilization
Giacomo d’Andrea, Ornella Di Marco, Francesco Maria Semeraro, et al.
Psychiatry Research Case Reports (2023) Vol. 2, Iss. 2, pp. 100188-100188
Open Access | Times Cited: 1
Evaluating passive physiological data collection during Spravato treatment
Todd M. Solomon, Matus Hajduk, Martin Majernik, et al.
Frontiers in Digital Health (2023) Vol. 5
Open Access | Times Cited: 1
Page 1

Scroll to top